HLA-DRA Antikörper (PE)
Kurzübersicht für HLA-DRA Antikörper (PE) (ABIN7540120)
Target
Alle HLA-DRA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- PE-Linked Anti-HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA) Polyclonal Antibody
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
Immunogen
- abo_RPC166Hu01-Recombinant HLA Class II Histocompatibility Antigen, DR Alpha Chain (HLA-DRA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- For flow cytometry, the suggested use of this reagent is 1-5 μL per 10^6 cells in 100 μL volume. Optimal working dilutions could be determined by end user.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.01 % Proclin-300, 50 % glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 4°C, protected from prolonged exposure to light.
-
-
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Andere Bezeichnung
- HLA Class II Histocompatibility Antigen, DR Alpha Chain
-
Hintergrund
- MHCDRa, HLADRa, Major Histocompatibility Complex Class II DR Alpha
-
Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-